Word

RESTORE IMMUNE HEALTH

Status

Dead

Status Code

602

Status Date

Friday, December 30, 2022

Serial Number

97007228

Mark Type

4000

Filing Date

Wednesday, September 1, 2021

Abandoned Date

Monday, December 19, 2022

Trademark Owner History

Statera Biopharma, Inc.

Classifications

41 Educational services, namely, conducting classes, seminars, conferences, and workshops and distributing printed course materials in conjunction therewith; providing on-line journals, namely, blogs in the medical, pharmaceutical and health fields

5 Pharmaceutical preparations and compounds for use in immune modulation, oncology, infectious diseases; pharmaceutical preparations for the treatment or prevention of immune-mediated diseases, Crohn's disease, multiple sclerosis, viral infections, HIV/AIDS, cancer, cell growth related disorders, cell proliferation related disorders, inflammatory diseases, ulcerative diseases, autoimmune diseases, autism, dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, stomach, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; anti-infectives; anti-inflammatories; vaccines; pharmaceutical preparations and compounds for reducing side effects in cancer treatment; pharmaceutical preparations and compounds for stimulating the immune system in an immuno-compromised patient; dietetic substances for medical purposes, namely, nutritional, vitamin and mineral supplements

42 Pharmaceutical and therapeutics research and development services for systemically delivered, locally active immune restorative conjugates, small molecules and peptides; research and development of systemically delivered, locally active immune restorative conjugates, small molecules and peptides in the pharmaceutical, therapeutics and biotechnology fields; research and product development of systemically delivered, locally active immune restorative conjugates, small molecules and peptides in the field of human therapeutics; research services using a platform of biological research tools and techniques for use in the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases and fibrotic diseases with systemically delivered, locally active immune restorative conjugates, small molecules and peptides; pharmaceutical product development of systemically delivered, locally active immune restorative conjugates, small molecules and peptides

Trademark Events

Dec 30, 2022

Abandonment Notice E-Mailed - Failure To Respond

Dec 30, 2022

Abandonment Notice Mailed - Failure To Respond

Dec 30, 2022

Abandonment - Failure To Respond Or Late Response

Jun 17, 2022

Notification Of Non-Final Action E-Mailed

Jun 17, 2022

Non-Final Action E-Mailed

Jun 17, 2022

Non-Final Action Written

Jun 6, 2022

Assigned To Examiner

Jan 18, 2022

Preliminary/Voluntary Amendment - Entered

Jan 15, 2022

Assigned To Lie

Jan 12, 2022

Teas Voluntary Amendment Received

Oct 14, 2021

New Application Office Supplied Data Entered In Tram

Sep 4, 2021

New Application Entered In Tram